These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12132787

  • 1. Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase.
    Coruzzi G, Coppelli G, Spaggiari S, Cavestro GM, Okolicsanyi L, Lo Giudice P, Pisano C, Tepperman BL.
    Dig Liver Dis; 2002 Jun; 34(6):403-10. PubMed ID: 12132787
    [Abstract] [Full Text] [Related]

  • 2. Gastrosparing effect of new antiinflammatory drug amtolmetin guacyl in the rat: involvement of nitric oxide.
    Pisano C, Grandi D, Morini G, Coppelli G, Vesci L, Lo Giudice P, Pace S, Pacifici L, Longo A, Coruzzi G, Carminati P.
    Dig Dis Sci; 1999 Apr; 44(4):713-24. PubMed ID: 10219827
    [Abstract] [Full Text] [Related]

  • 3. Gastroprotective effect and mechanism of amtolmetin guacyl in mice.
    Li YH, Li J, Huang Y, Lu XW, Jin Y.
    World J Gastroenterol; 2004 Dec 15; 10(24):3616-20. PubMed ID: 15534917
    [Abstract] [Full Text] [Related]

  • 4. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G, Montrone F, Lazzaroni M, Manzionna G, Caruso I.
    Ital J Gastroenterol Hepatol; 1999 Dec 15; 31(5):378-85. PubMed ID: 10470596
    [Abstract] [Full Text] [Related]

  • 5. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.
    Kirkova M, Alexandova A, Kesiova M, Todorov S.
    Auton Autacoid Pharmacol; 2007 Apr 15; 27(2):99-104. PubMed ID: 17391279
    [Abstract] [Full Text] [Related]

  • 6. Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM, Bettelli E.
    Eur J Pharmacol; 2003 Apr 25; 467(1-3):173-83. PubMed ID: 12706472
    [Abstract] [Full Text] [Related]

  • 7. Morphological features of rat gastric mucosa after acute and chronic treatment with amtolmetin guacyl: comparison with non-selective and COX-2-selective NSAIDs.
    Morini G, Guaita E, Lazzaretti M, Grandi D, Coruzzi G.
    Digestion; 2003 Apr 25; 68(2-3):124-32. PubMed ID: 14610345
    [Abstract] [Full Text] [Related]

  • 8. Gastric effects of the novel non-steroidal anti-inflammatory drug amtolmetin guacyl.
    Coruzzi G, Bertaccini G.
    Nutrition; 1999 Apr 25; 15(4):325-6. PubMed ID: 10319368
    [No Abstract] [Full Text] [Related]

  • 9. Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM.
    Arzneimittelforschung; 2001 Sep 25; 51(9):737-42. PubMed ID: 11642006
    [Abstract] [Full Text] [Related]

  • 10. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems in different models of gastrointestinal injury.
    Kirkova M, Kesiova M, Konstantinova S, Alexandrova A, Petrov L, Tsvetanova E, Todorov S.
    Auton Autacoid Pharmacol; 2007 Jan 25; 27(1):63-70. PubMed ID: 17199877
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis].
    Biasi G, Marcolongo R.
    Minerva Med; 2001 Oct 25; 92(5):315-24. PubMed ID: 11675575
    [Abstract] [Full Text] [Related]

  • 12. The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM.
    Eur J Pharmacol; 2000 Jan 10; 387(2):233-44. PubMed ID: 10650165
    [Abstract] [Full Text] [Related]

  • 13. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
    Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, Kwiecień S, Pajdo R, Ptak A, Pawlik M, Hahn E.
    Dig Liver Dis; 2000 Oct 10; 32(7):583-94. PubMed ID: 11142556
    [Abstract] [Full Text] [Related]

  • 14. Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.
    Tubaro E, Belogi L, Mezzadri CM, Ruco L, Stopacciaro A.
    Arzneimittelforschung; 1995 Dec 10; 45(12):1298-302. PubMed ID: 8595088
    [Abstract] [Full Text] [Related]

  • 15. Potential antioxidant activity of celecoxib and amtolmetin guacyl: in vitro studies.
    Kirkova M, Alexandova A, Kesiova M, Tsvetanova E, Georgieva A, Todorov S.
    Auton Autacoid Pharmacol; 2007 Jan 10; 27(1):13-8. PubMed ID: 17199871
    [Abstract] [Full Text] [Related]

  • 16. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide.
    Brzozowski T, Konturek PC, Sliwowski Z, Drozdowicz D, Pajdo R, Stachura J, Hahn EG, Konturek SJ.
    J Physiol Pharmacol; 1997 Dec 10; 48(4):699-717. PubMed ID: 9444618
    [Abstract] [Full Text] [Related]

  • 17. Protective effect of amtolmetin guacyl versus placebo diclofenac and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage.
    Riezzo G, Chiloiro M, Montanaro S.
    Dig Dis Sci; 2001 Aug 10; 46(8):1797-804. PubMed ID: 11508686
    [Abstract] [Full Text] [Related]

  • 18. Involvement of nitric oxide pathway in the anti-inflammatory effect of modafinil on indomethacin-, stress-, and ethanol -induced gastric mucosal injury in rat.
    Dejban P, Eslami F, Rahimi N, Takzare N, Jahansouz M, Dehpour AR.
    Eur J Pharmacol; 2020 Nov 15; 887():173579. PubMed ID: 32950497
    [Abstract] [Full Text] [Related]

  • 19. Nitro-arginine methyl ester, a non-selective inhibitor of nitric oxide synthase reduces ibuprofen-induced gastric mucosal injury in the rat.
    Abraham P, K I, K D.
    Dig Dis Sci; 2005 Sep 15; 50(9):1632-40. PubMed ID: 16133962
    [Abstract] [Full Text] [Related]

  • 20. [A clinical study on the anti-inflammatory activity and gastrointestinal tolerability of amtolmetin guacyl, a new NSAID, compared with diclofenac in aged patients with osteoarticular diseases].
    Tavella A, Ursini G.
    Clin Ter; 1997 Nov 15; 148(11):543-8. PubMed ID: 9494257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.